.
Live Nation Shares Plunge on Antitrust Investigation Report
Live Nation has been the focus of antitrust attention since it joined forces with Ticketmaster in 2010.
Tag: Wall Street Analyst
Retail Sales Surge in March, Surpassing Wall Street Expectations
As economists debate whether the U.S. economy can remain resilient in a high interest rate environment, the March retail sales report provided a glimpse into the health of consumers.
One Wall Street analyst sees 17% upside for Delta Air Lines shares
Delta's stock isn't quite a bargain yet, but at least it's profitable again.
ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?
While the market has been hot so far this year, there is no shortage of moderately priced stocks with impressive growth potential. In biotechnology, there are many companies that can leverage their technological strengths to improve all aspects of health and medicine. From genetics to minimally invasive disease diagnostics, this article will look at three strong buy-rated stocks - ZTS, EXAS, and AZN - that I believe are among the best investments in the biopharmaceutical space. Although the stocks of individual biotech and biopharmaceutical companies are
One Wall Street analyst sees 20% upside for Intuitive Surgical stock. Is the stock worth buying near all-time highs?
The target price of $462 may seem ambitious, but it is achievable.
English 
Chinese